Modern aspects on Shigella pathogenecity and vaccine development - a review

• Autorzy: Pal P.
• Języki publikacji: EN

Abstrakty

EN

Shigella species are intracytosolic Gram-negative invasive enteropathogenic bacteria, causing the rupture, invasion and inflammatory destruction of the human colonic epithelium. They utilize the host cytoskeletal components to form propulsive actin tails. The so-called invasive phenotype of Shigella is linked to expression of a type III secretory system (TTSS) injecting effector proteins into the epithelial cell membrane and cytoplasm, thereby inducing local but massive changes in the cell cytoskeleton that lead to bacterial internalization into non-phagocytic intestinal epithelial cells. The molecular and cellular bases of this invasive phenotype essentially encompass crossing of the epithelial lining, apoptotic killing of macrophages, entry into epithelial cells, and escape into the cytoplasm, followed by cell-to-cell spread. Intracellular colonization is likely to protect the micro-organisms from killing by humoral and cellular effectors of the innate immune response. Concurrently, the capacity of Shigella to reprogram invaded epithelial cells to produce proinflammatory mediators plays a major role in the strong inflammatory profile of the disease. This profile is likely to impact on the nature and quality of the adaptive response, which is dominated by humoral protection at the mucosal level. In recent years, a large amount of information has been generated regarding the host, pathogen and environmental factors that impact the pathogenesis of shigellosis at the cellular and molecular level. This review summarizes what is currently known about Shigella, detailing those factors that contribute to pathogenesis and examining the current progress in the development of a vaccine.

Słowa kluczowe

EN

Shigella; vaccine; development; pathogenicity; pathogenesis; enteropathogen; bacteria

• Wydawca: -
• Czasopismo: International Letters of Natural Sciences
• Rocznik: 2014
• Tom: 12
• Numer: 1
• Opis fizyczny: p.12-20,ref.

Twórcy

autor

Pal P.

• Department of Zoology, Scottish Church College, 1 and 3 Urquhart Square, Kolkata - 700006, India

Bibliografia

• [1] Alto N.M., Shao F., Lazar C.S., Brost R.L., Chua G., Matto S., McMahon S.A., Ghosh P., Hughes T.R., Boone C., Dixon J.E., Cell 124 (2006) 133-145.
• [2] Ashkenazi S., Passwell J.H, Harlev E., Miron D., Dagan R., Ramon R., Farzam N., Majadly F., Bryla D.A., Karpas A.B., Robbins J.B., Schneerson R., J Infect Dis 179 (1999) 1565-1568.
• [3] Barnoy S., Baqar S., Kaminski R.W., Collins T., Nemelka K., Hale T.L., Ranallo R.T., Venkatesan M.M., Vaccine 29 (2011) 6371-6378.
• [4] Bedford L., Fonseka S., Boren T., Ranallo R.T, Suvarnapunya A.E, Lee J.E., Barnoy S., venkatesan M.M., Gut Microbes 2 (2011) 244-251.
• [5] Bompard G., Caron E., J Cell Biol 166 (2004) 957-962.
• [6] Buchrieser C., Glaser P., Rusniok C., Nedjari H., D’Hauteville H., Kunst F., Sansonetti P., Parsot C., Mol Microbiol 38 (2000) 760-771.
• [7] Clerc P., Sansonetti P.J., Infect Immun. 55 (1987) 2681-2688.
• [8] Cohen D., Green M., Block C., Slepon R., Ofek I., J Clin Microbiol 29 (1991) 386-389.
• [9] Costa S.C., Schmitz A.M., Jahufar F.F., Boyd J.D., Cho M.Y., Glicksman M.A., Lesser C.F., M Bio 3 (2012) e00243-00211.
• [10] DuPont H.L., Levine M.M., Hornick R.B., Formal S.B., J Infect Dis 159 (1989) 1126-1128.
• [11] Egile C., Loisel T.P., Laurent V. Li R., Pantaloni D., Sansonetti P.J., Carlier M.F., J Cell Biol 146 (1999) 1319-1332.
• [12] Ewing W.H., J Bacteriol 57 (1949) 633-638.
• [13] Fukushima M., Kakinuma K., Kawaguchi R., J Clin Microbiol 40 (2002) 2779-2785.
• [14] George D.T., Mathesius U., Behm C.A., Verma N.K., PLoS ONE 9(4) (2014) e94954.
• [15] Goldberg M.B., Microbiol Mol Biol Rev 65 (2001) 595-626.
• [16] Hachani A., Biskri L., Rossi G., Marty A., Menard R., Sansonetti P.J., Parsot C., Van Nhieu G.T., Bernardini M.L., Allaoui A., Microbes Infect 10 (2008) 260-268.
• [17] Handa Y., Suzuki M., Ohya K., Iwai H., Ishijima N., Koleske A.J., Fukui Y., Sasakawa C., Nat Cell Biol 9 (2007) 121-128.
• [18] Heine S.J., Diaz-McNair J., Martinez-Becerra F.J., Choudhari S.P., Clements J.D., Picking W.L., Pasetti M.F., Vaccine 31 (2013) 2919-2929.
• [19] Ho H.Y., Rohatgi R., Lebensohn A.M., Le Ma., Li J., Gygi S.P., Kirschner M.W., Cell 118 (2004) 203-216.
• [20] Huang Z., Sutton S.E., Wallenfang A.J., Orchard R.C., Wu X., Feng Y., Chai J., Alto N.M., Nat Struct Mol Biol 16 (2009) 853-860.
• [21] Islam D., Bandholtz L., Nilsson J., Wigzell H., Christensson B., Agerberth B., Gudmundsson G., Nat Med 7 (2001) 180-185.
• [22] Jiang Y. et al., Plasmid 54 (2005) 149-159.
• [23] Jin Q. et al., Nucleic Acids Res 30 (2002) 4432-4441.
• [24] Kotloff K.L., Winikoff J.P., Ivanoff B., Clemens J.D., Swerdlow D.L., Sansonetti P.J., Adak G.K., Levine M.M., Bull WHO 77 (1999) 651-666.
• [25] Lan R., Alles M.C., Donohoe K., Martinez M.B., Reeves P.R., Infect Immun. 72 (2004) 5080-5088.
• [26] Lan R., Reeves P.R., Microbes Infect 4 (2002) 1125-1132.
• [27] Levine M.M., Kotloff K.L., Barry E.M., Pasetti M.F., Sztein M.B, Nat Rev Microbiol 5 (2007) 540-553.
• [28] Leung Y., Ally S., Goldberg M.B., Cell Host Microbe 3 (2008) 39-47.
• [29] Lommel S., Benesch S., Rottner K., Franz T., Wehland J., Kuhn R., EMBO Rep 2 (2001) 850-857.
• [30] Martinez-Becerra F.J. et al., Infect Immun 80 (2012) 1222-1231.
• [31] Martinez-Becerra F.J., Scobey M., Harrison K., Choudhari S.P., Quick A.M., Joshi S.B., Middauqh C.R., Picking W.L., Vaccine 31 (2013) 2667-2672.
• [32] Meitert T., Pencu E., Ciudin L., Tonciu M., Arch Roum Pathol Exp Microbiol 43 (1984) 251-278.
• [33] Mel D.M., Arsic B.L., Radovanovic M.L., Litvinjenko S.A., Acta Microbiol Acad Sci Hung 21 (1974) 109-114.
• [34] Mel D., Gangarosa E.J., Radovanovic M.L., Arsic B.L., Litvinjenko S., Bull World Health Org 45 (1971) 457-464.
• [35] Menard R., Sansonetti P., Parsot C., EMBO J 13 (1994) 5293-5302.
• [36] Nie H. et al., BMC Genomics 7 (2006) 173.
• [37] Niebuhr K., Jouihri N., Allaoui A., Gounon P., Sansonetti P.J., Parsot C., Mol Microbiol 38 (2000) 8-19.
• [38] Ochman H., Whittam T., Caugant D.A., Selander R.K., J Gen Microbiol 129 (1983) 2715-2726.
• [39] Ohya K., Handa Y., Ogawa M., Suzuki M., Sasakawa C., J Biol Chem 280 (2005) 24022-24034.
• [40] Ogawa M., Sasakawa C., Cell Microbiol 8 (2006) 177-184.
• [41] Ogawa M., Susuki T., Tatsuno I., Abe H., Sasakawa C., Mol Microbiol 48 (2003) 913-931.
• [42] Page A.L., Sansonetti P., Parsot C., Mol Microbiol 43 (2002) 1533-1542.
• [43] Parsot C., FEMS Microbiol Lett 252 (2005) 11-18.
• [44] Passwell J.H., Ashkenazi S., Banet-Levi Y., Ramon R., Farzan N., Lerner-Geva L., Vaccine 28 (2010) 231-235.
• [45] Passwell J.H. et al., Pediatr Infect Dis J 22 (2003) 701-706.
• [46] Passwell J.H., Freier S., Shor R., Farzan N., Block C., Lison M., Shiff E., Ashkenazi S., Pediatr Infect Dis J 14 (1995) 859-865.
• [47] Peng J., Zhang X., Yang J., Wang J., Yang E., Bin W., Wei C., Sun M., Jin Q., BMC Genomics 7 (2006) 218.
• [48] Pupo G.M., Karaolis D.K., Lan R., Reeves P.R., Infect Immun 65 (1997) 2685-2692.
• [49] Pupo G.M., Lan R., Reeves P.R., Proc Natl Acad Sci USA 97 (2000) 10567-10572.
• [50] Ranallo R.T., Fonseka S., Boren T.L., Bedford L.A., Kaminski R.W., Thakkar S., Venkatesan M.M., Vaccine 30 (2012) 5159-5171.
• [51] Rolland K., Lambert-Zechovsky N., Picard B., Denamur E., Microbiology 144 (1998) 2667-2672.
• [52] Sansonetti P.J., PloS Med 3 (2006) e354.
• [53] Sansonetti P.J., Hale T.L., Dammin G.J., Kapfer C., Collins H.H., Formal S.B., Infect Immun 39 (1983) 1392-1402.
• [54] Sansonetti P.J., Kopecko D.J., Formal S.B., Infect Immun. 35 (1982) 852-860.
• [55] Sasakawa C., Kamata K., Sakai T., Murayama S.Y., Makino S., Yoshikawa M., Infect Immun 54 (1986) 470-475.
• [56] Schmitz A.M., Morrison M., Agunwamba A.O., Nibert M.L., Lesser C.F., Nat Methods 6 (2009) 500-502.
• [57] Shepherd J., Wang G.L., Reeves P.R., Infect Immun. 68 (2000) 6056-6061.
• [58] Shiga K., Saikingaku Zasshi 25 (1897) 790-810.
• [59] Snaper S.B. et al., Nat Cell Biol 3 (2001) 897-904.
• [60] Suzuki T., Miki H., Takenawa T., Sasakawa C., EMBO J 17 (1998) 2767-2776.
• [61] Tran Van Nhieu G., Enninga J., Sansonetti P., Grompone G., Curr Opin Microbiol 8 (2005) 16-20.
• [62] Venkatesan M.M., Fernandez-Prada C., Buysse J.M., Formal S.B., Hale T.L., Vaccine 9 (1991) 358-363.
• [63] Venkatesan M.M., Goldberg M.B., Rose D.J., Grotbeck E.J., Burland V., Blattner F.R., Infect Immun 69 (2001) 3271-3285.
• [64] Wei J. et al., Infect Immun. 71 (2003) 2775-2786.
• [65] WHO (2006) Geneva, Switzerland http://www.who.int/topics/global_burden_of_disease/en/
• [66] Yang F. et al., Nucleic Acids Res 33 (2005) 6445-6458.
• [67] Yang J., Nie H., Chen L., Zhang X., Yang F., Xu X., Zhu Y., Yu J., Jin Q., J Mol Evol 64 (2007) 71-79.